Constitutive release of metalloproteinase-9 (92-kd Type IV collagenase) by Kaposi's sarcoma cells

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 18, Issue 3, 1998, Pages 203-209

  Blankaert, D ^a   Simonart, Th ^b   Van Vooren, J P ^b   Parent, D ^b   Liesnard, C ^b   Farber, C M ^b   Marique, T ^a   Werenne, J ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b ERASME HOSPITAL   (Belgium)

Author keywords

Endothelial cells; Kaposi's sarcoma; Metalloproteinases; Tissue inhibitor of metalloproteinases

Indexed keywords

COLLAGENASE; METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANGIOGENESIS; ARTICLE; CANCER INVASION; CELL INFILTRATION; CELL PROLIFERATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME RELEASE; HISTOGENESIS; HUMAN; HUMAN CELL; INFLAMMATORY CELL; KAPOSI SARCOMA; METASTASIS POTENTIAL; PRIORITY JOURNAL; SARCOMA CELL; SPINDLE CELL;

EID: 0032126422     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199807010-00002     Document Type: Article

References (48)

1. Roth WK, Brandstetter H, Stürzl M. Cellular and molecular features of HIV-associated Kaposi's sarcoma. AIDS 1992;6:895-913.
2. Tappero JW, Conant MA, Wolfe SF, Berger TG. Kaposi's sarcoma. Epidemiology, pathogenesis, histology, clinical spectrum, staging criteria and therapy. J Am Acad Dermatol 1993;28:371-95.
3. Uccini S, Ruco LP, Monardo F, et al. Co-expression of endothelial cell and macrophage antigens in Kaposi's sarcoma cells. J Pathol 1994;173:23-31.
4. Scully PA, Steinman HK, Kennedy C, Trueblood K, Frisman DM, Voland JR. AIDS-related Kaposi's sarcoma displays differential expression of endothelial surface antigens. Am J Pathol 1988;130: 244-51.
5. Rabkin CS, Janz S, Lash A, et al. Monoclonal origin of multicentric Kaposi's sarcoma lesions. N Engl J Med 1997;336:988-93.
6. Simonart T, Noel JC, Van Vooren JP, et al. DNA diploidy in AIDS-related and steroid-induced Kaposi's sarcoma. Br J Dermatol 1997;136:804.
7. Fukunaga M, Silverberg SG. Kaposi's sarcoma in patients with acquired immune deficiency syndrome. Cancer 1990;66:758-64.
8. Albini A, Fontanini G, Masiello L, et al. Angiogenic potential in vivo by Kaposi's sarcoma cell-free supernatants and HIV-1 tat product: inhibition of KS-like lesions by tissue inhibitor of metalloproteinase-2. AIDS 1994;8:1237-44.
9. + T cells. Science 1988;242:426-30.
10. Roth WK, Werner S, Risau W, Remberger K, Hofschneider PH. Cultured, AIDS-related Kaposi's sarcoma cells express endothelial cell markers and are weakly malignant in vitro. Int J Cancer 1988; 42:767-73.
11. Corbeil J, Evans LA, Vasak E, Cooper DA, Penny R. Culture and properties of cells derived from Kaposi's sarcoma. J Immunol 1991;146:2972-6.
12. Albini A, Repetto L, Carlone S, et al. Characterization of Kaposi's sarcoma-derived cell cultures from an epidemic and a classic case. Int J Oncol 1992;1:723-30.
13. Benelli R, Repetto L, Carlone S, Parravicini C, Albini A. Establishment and characterization of two new Kaposi's sarcoma cell cultures from an AIDS and a non-AIDS patient. Res Virol 1994; 145:251-9.
14. Fiorelli V, Gendelman R, Samaniego F, Markham PD, Ensoli B. Cytokines from activated T cells induce normal endothelial cells to acquire the phenotype and functional features of AIDS-Kaposi's sarcoma spindle cells. J Clin Invest 1995;95:1723-34.
15. Barillari G, Bounaguro L, Fiorelli V, et al. Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. Implications for AIDS Kaposi's sarcoma pathogenesis. J Immunol 1992;149:3727-34.
16. Bussolino F, Arese M, Montrucchio G, et al. Platelet activating factor produced in vitro by Kaposi's sarcoma cells induces and sustains in vivo angiogenesis. J Clin Invest 1995;96:940-52.
17. Ensoli B, Gendelman R, Markham PD, et al. Synergy between basic fibroblast growth factor and human immunodeficiency virus type 1 Tat protein in induction of Kaposi's sarcoma. Nature 1994; 321:674-80.
18. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994;266:1865-9.
19. Noel JC, Hermans P, Andre J, et al. Herpesvirus-like DNA sequences and Kaposi's sarcoma. Relationship to epidemiology, clinical spectrum, and histologic features. Cancer 1996;77:2132-6.
20. Declerck YA, Perez N, Shimada H, Boone TC, Langley KE, Taylor SM. Inhibition of invasion and metastases in cells transfected with an inhibitor of metalloproteinases. Cancer Res 1992;52: 707-8.
21. Goldberg GI, Strongin A, Collier LE, Genrich LT, Marmer BL. Interaction of the 92-K DA type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerisation, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J Biol Chem 1992;267:4583-91.
22. Liotta LA, Steeg PS, Stetler-Stenvenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991;64:327-36.
23. Sato H, Kido Y, Mai M, et al. Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. Oncogene 1992; 7:77-83.
24. Gimbrone M.A. Progress in hemostasis and thrombosis. New York: Grune & Stratton, 1976:1-28.
25. Sciacca FL, Stürzl M, Bussolio F, et al. Expression of adhesion molecules, platelet-activating factor, and chemokines by Kaposi's sarcoma cells. J Immunol 1994;153:4816-25.
26. Pamer J, Plettenberg A, Weninger W, et al. The CD40 antigen is expressed by endothelial cells and tumor cells in Kaposi's sarcoma. Am J Pathol 1996;148:1387-96.
27. Simonart T, Noel JC, Liesnard C, et al. Kaposi's sarcoma and herpes 8 virus: a word of caution. Dermatology 1996;193:272.
28. Heusen C, Dowdle EB. Electrophoretic analysis of plasminogens activators in polyacrylamide gels containing SDS and copolymerized substrate. Ann Biochem 1980;102:192-202.
29. Kleiner DE, Stetler-Stevenson WG. Quantitative zymography, detection of picograms quantities of gelatinases. Ann Biochem 1994; 218:325-9.
30. Staskus PW, Masiarz FR, Pallanck LJ, Hawkes SP. The 21-kd protein is a transformation-sensitive metalloproteinase inhibitor of chicken fibroblasts. J Biol Chem 1991;266:449-54.
31. Miyazaki K, Umenishi F, Funahashi K, Koshikawa N, Yasumitsu H, Umeda M. Activation of TIMP-2/Progelatinase A complex by stromelysin. Biochem Biophys Res Commun 1992;185:852-9.
32. Lefebvre V, Peeters-Joric C, Vaes G. Production of gelatin degrading matrix metalloproteinases ("type IV collagenases") and inhibitors by articular chondrocytes during their differentiation by serial subcultures and under stimulation by interleukin-1 and tumor necrosis factor-α. Biochim Biophys Acta 1991;1094:8-18.
33. Montesano R, Orci L. Tumor-promoting phorbol esters induces angiogenesis in vitro. Cell 1985;42:469-77.
34. Hanemaaijer R, Hoolwisk P, le Clerq L, de Vree WJA, Van Hinsbergh VWM. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Biochem J 1993; 296:803-9.
35. Foda HD, George S, Conner C, Drews M, Tompkins DC, Zucker S. Activation of human umbilical vein endothelial cell progelatinase A by phorbol myristate acetate: a protein kinase C-dependent mechanism involving a membrane-type matrix metalloproteinase. Lab Invest 1996;74:538-45.
36. De Clerck YA, Yean TD, Ratzkin BJ, Lu HS, Langley KE. Purification and characterization of two related but distinct metalloproteinase inhibitors secreted by bovine aortic endothelial cells. J Biol Chem 1989;264:17445-53.
37. Salahuddin SZ, Nakamura S, Biberfeld P, et al. Angiogenic properties of Kaposi's sarcoma derived cells after long-term culture in vitro. Science 1988;1242:430-33.
38. Cornali E, Zietz C, Benelli R, et al. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma. Am J Pathol 1996;149:1851-69.
39. Stürzl M, Brandstetter H, Zietz C, et al. Identification of interleukin-1 and platelet-derived growth factor-B as major mitogens for the spindle cells of Kaposi's sarcoma: a combined in vitro and in vivo analysis. Oncogene 1995;10:2007-16.
40. Sarén P, Welgus HG, Kovanen PT. TNF-α and IL-1β selectively induce expression of 92-kd gelatinase by human macrophages. J Immunol 1996;157:4159-65.
41. Cornelius LA, Nehring LC, Roby JD, Parks WC, Welgus HG. Human dermal microvascular endothelial cells produce matrix metalloproteinases in response to angiogenic factors and migration. J Invest Dermatol 1995;105:170-6.
42. Ries C, Kolb H, Petrides PE. Regulation of 92-KD gelatinase release in HL-60 leukemia cells: tumor necrosis factor-α as an autocrine stimulus for basal- and phorbol ester-induced secretion. Blood 1994;83:3638-46.
43. Karelina TV, Goldberg GI, Eisen AZ. Matrix metalloproteinases in blood vessel development in human fetal skin and in cutaneous tumors. J Invest Dermatol 1995;105:411-7.
44. Ensoli B, Nakamura S, Salahuddin Z, et al. AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science 1989;242:223-6.
45. Cai J, Gill PS, Masood R, et al. Oncostatin M is an autocrine growth factor in Kaposi's sarcoma. Am J Pathol 1994;145:74-9.
46. Miles SA, Rezai AR, Salazar-Gonzalez JF, et al. AIDS-Kaposi's sarcoma-derived cells produce and respond to interleukin-6. Proc Natl Acad Sci USA 1990;87:4068-72.
47. Gill P, Rarier M, Bernstein-Singer M, et al. Treatment of advanced Kaposi's sarcoma using a combination of bleomycin and vincristine. Am J Clin Oncol 1990;13:315-9.
48. Lilenbaum RC, Ratner L. Systemic treatment of Kaposi's sarcoma: current status and future directions. AIDS 1994;8:141-51.